INTRODUCTION: Limited literature exists on oncological chest wall reconstruction in the paediatric population, with the field still largely undecided on the best surgical reconstructive techniques to employ. The use of biological grafts/meshes is gaining popularity in certain adult surgical procedures but their use in paediatric procedures is rarely reported in the literature. We present the outcomes of our institution's multidisciplinary approach to managing paediatric chest wall tumours as well as our experience with the use of biological grafts for chest wall reconstruction following oncological resections. METHODS: Data were analysed retrospectively from eight paediatric patients who were treated for primary chest wall tumours between 2010 and 2018. RESULTS: The tumours comprised two lipoblastomas, three Ewing's sarcomas, an undifferentiated sarcoma with osteosarcomatous differentiation, a high grade undifferentiated sarcoma and a myofibroma. Seven of the eight patients underwent chest wall reconstruction with a biological graft. There were no postoperative mortalities and no evidence of recurrence in any of the patients in the series. No further chest wall operations were required and there were no postoperative infection related complications. CONCLUSIONS: We support the use of biological grafts for chest wall reconstruction after oncological resections and maintain that a multidisciplinary approach is essential for the management of paediatric chest wall tumours.
INTRODUCTION: Limited literature exists on oncological chest wall reconstruction in the paediatric population, with the field still largely undecided on the best surgical reconstructive techniques to employ. The use of biological grafts/meshes is gaining popularity in certain adult surgical procedures but their use in paediatric procedures is rarely reported in the literature. We present the outcomes of our institution's multidisciplinary approach to managing paediatric chest wall tumours as well as our experience with the use of biological grafts for chest wall reconstruction following oncological resections. METHODS: Data were analysed retrospectively from eight paediatric patients who were treated for primary chest wall tumours between 2010 and 2018. RESULTS: The tumours comprised two lipoblastomas, three Ewing's sarcomas, an undifferentiated sarcoma with osteosarcomatous differentiation, a high grade undifferentiated sarcoma and a myofibroma. Seven of the eight patients underwent chest wall reconstruction with a biological graft. There were no postoperative mortalities and no evidence of recurrence in any of the patients in the series. No further chest wall operations were required and there were no postoperative infection related complications. CONCLUSIONS: We support the use of biological grafts for chest wall reconstruction after oncological resections and maintain that a multidisciplinary approach is essential for the management of paediatric chest wall tumours.
Authors: R C Shamberger; M P Laquaglia; M D Krailo; J S Miser; D J Pritchard; M C Gebhardt; J H Healey; N J Tarbell; C J Fryer; P A Meyers; H E Grier Journal: J Thorac Cardiovasc Surg Date: 2000-06 Impact factor: 5.209
Authors: David W Tuggle; P Cameron Mantor; David S Foley; Michele M Markley; Nikola Puffinbarger Journal: J Pediatr Surg Date: 2004-04 Impact factor: 2.545
Authors: Carol Oliveira; Mohammed Zamakhshary; Tariq Alfadda; Fahad Alhabshan; Hisham Alshalaan; Stephen Miller; Peter C W Kim Journal: J Pediatr Surg Date: 2012-05 Impact factor: 2.545
Authors: N Baldan; G Munegato; A Di Leo; E Lauro; E Morpurgo; S Pianigiani; D Briscolini; R Ferrara; V Fiscon; A Brolese; G De Manzoni; G Baldazzi; D Snidero; S Merigliano; F Ricci; E Laterza; R Merenda; R Gianesini Journal: Hernia Date: 2019-01-19 Impact factor: 4.739